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Abstract
Endurance exercise begun with reduced muscle glycogen stores seems to potentiate
skeletal muscle protein abundance and gene expression. However, it is unknown
whether this greater signaling responses is due to performing two exercise sessions
in close proximity—as a first exercise session is necessary to reduce the muscle glycogen stores. In the present study, we manipulated the recovery duration between a
first muscle glycogen-depleting exercise and a second exercise session, such that the
second exercise session started with reduced muscle glycogen in both approaches but
was performed either 2 or 15 hours after the first exercise session (so-called “twicea-day” and “once-daily” approaches, respectively). We found that exercise twice-a-day
increased the nuclear abundance of transcription factor EB (TFEB) and nuclear factor of
activated T cells (NFAT) and potentiated the transcription of peroxisome proliferatoractivated receptor-ɣ coactivator 1-alpha (PGC-1α), peroxisome proliferatoractivated receptor-alpha (PPARα), and peroxisome proliferator-activated receptor

Abbreviations: 18S, 18S ribosomal RNA; ACTB, actin beta; AMPK, 5′ adenosine monophosphate-activated protein kinase; CD-36, fatty acid translocase
cluster of differentiation 36; CHCHD4, coiled-coil-helix-coiled-coil-helix domain containing 4; CHO, carbohydrate; COX IV, cytochrome c oxidase subunit
IV; CPT1, carnitine palmitoyltransferase 1; CS, citrate synthase; GLUT4, Glucose transporter type 4; NFAT, nuclear factor of activated T cells; NDUF,
NADH dehydrogenase subunit; p21, p21 protein; p38MAPK, p38 mitogen-activated protein kinase; p53, p53 protein; PDK4, pyruvate dehydrogenase kinase
4; PFK, phosphofructokinase; PGC-1α, peroxisome proliferator-activated receptor-ɣ coactivator 1-alpha; PHF20, PHF20 protein; PPARɣ, peroxisome
proliferator-activated receptor-delta; PPARα, peroxisome proliferator-activated receptor-alpha; PPARβ/δ, peroxisome proliferator-activated receptor beta/
delta; SDH, succinate dehydrogenase; TBP, TATA box-binding protein; Tfam, mitochondrial transcription factor A; TFEB, transcription factor EB; UCP3,
uncoupling protein 3; β-HAD, 3-hydroxyacyl-CoA dehydrogenase.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited and is not used for commercial purposes.
© 2019 The Authors. The FASEB Journal published by Wiley Periodicals, Inc. on behalf of Federation of American Societies for Experimental Biology
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beta/delta (PPARβ/δ) genes, in comparison with the once-daily exercise. These results suggest that part of the elevated molecular signaling reported with previous
“train-low” approaches might be attributed to performing two exercise sessions in
close proximity. The twice-a-day approach might be an effective strategy to induce
adaptations related to mitochondrial biogenesis and fat oxidation.
KEYWORDS
high-intensity exercise, mitochondrial biogenesis, molecular signaling, muscle glycogen, transcription
factor

1

|

IN T RO D U C T IO N

Endurance exercise is a powerful stimulus affecting cytoplasmic and nuclear proteins, and genes encoding mitochondrial proteins, with a subsequent increase in mitochondrial
biogenesis (ie, the generation of new mitochondrial components leading to increased mitochondrial content and respiratory function).1-8 While these responses are affected by the
nature of the exercise (eg, the exercise intensity2,9,10), there
is evidence substrate availability is also a potent modulator
of this response.11-14 It has been hypothesized that initiating
endurance exercise with low muscle glycogen stores (the
so-called “train-low” approach) results in a greater increase
in the content of nuclear proteins15,16 and in the transcription of genes17-20 associated with mitochondrial biogenesis.
However, although the “train-low” strategy has been reported
to potentiate skeletal muscle signaling responses related to
mitochondrial biogenesis,17,21-23 there are also contrasting
findings showing no effects24,25 and a consensus is yet to be
reached.
Some of the evidence supporting the “train-low” approach
is based on performing a first exercise session to reduce
muscle glycogen stores, which is followed by a second exercise session 1-3 hours later—the so-called “twice-a-day”
approach.21-24,26-28 Although the second exercise session will
start with reduced muscle glycogen stores, it is difficult to
determine if any changes are due to performing the second
exercise session with low muscle glycogen or performing the
second exercise session soon after the first. The transcriptional responses of many genes associated with mitochondrial biogenesis peak approximately 3 hours post exercise
and return to basal levels within 8-12 hours,5,14,29-32 including
the transcription of peroxisome proliferator-activated
receptor-ɣ coactivator 1-alpha (PGC-1α)—considered a key
regulator of mitochondrial biogenesis.33 Thus, it is possible
that reported increases in gene expression with the twicea-day approach can be attributed to performing the second
exercise session close to the first, when there is an already
increased expression of genes associated with mitochondrial
biogenesis. In fact, recent findings suggest that improvements

in mitochondrial efficiency after a 3-week train-low approach
are linked to performing the second exercise session close to
the first exercise session rather than due to reduced muscle
glycogen per se.34 The molecular signaling responses associated with this greater mitochondrial adaptation to twicea-day training is, however, unknown.
The aim of this study was to investigate whether greater
exercise-induced signaling with the “train-low” approach
can be attributed to the cumulative effects of performing two
exercise sessions in close proximity. In the present study, we
manipulated the recovery duration between a first muscle
glycogen-depleting exercise and a second exercise session (ie,
“once-daily” vs “twice-a-day” approach). In the once-daily
condition, muscle glycogen content was reduced via evening
exercise (prolonged exercise) followed by a carbohydraterestricted period, and a second exercise (ie, high-intensity interval exercise) was performed the next day (ie, 15 h between
exercise sessions). In the twice-a-day condition, the same
exercises were used but with a short recovery period between
exercise sessions (ie, 2 h between exercise sessions). A highintensity interval exercise session undertaken without a prior
muscle glycogen-depleting exercise served as a control. We
hypothesized that the “twice-a-day” approach would induce a
more elevated molecular signaling response during the second
exercise session, compared to the “once-daily” approach.

2
2.1

|

M ATERIAL S AND M ETHOD S

|

Participants

Eight healthy men (age: 30.8 ± 3.5 years, body mass:
78.7 ± 9.9 kg, height: 1.76 ± 0.07 m, body fat: 13.6 ± 5.1%,
̇ 2peak]: 37.1 ± 6.4 mL·kg−1·min−1, peak
peak oxygen uptake [VO
power derived from a graded exercise test: 229.6 ± 38.2 W,
and first and second lactate thresholds: 78.1 ± 20.9 and
170.0 ± 37.7 W, respectively) participated in this study.
Participants were recruited by word-of-mouth conversations,
online postings, and flyers posted at the University Campus.
Participants were considered eligible if they were physically
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active (more than 3 times/week) and accustomed to cycling.
Participants were excluded if they had history or signs of cardiac, metabolic, or respiratory diseases and/or had been using
any prescription medications. A medical doctor administered
a medical history screening tool for this purpose. Participants
were informed about the procedures, risks, and benefits associated with the protocol, before they signed a consent form
agreeing to participate in this study, which was approved
by the Research Ethics Committee of Federal University of
Pernambuco (approval number: 30378414.8.0000.5208). The
study was conducted according to the principles presented in
the Declaration of Helsinki.
Sample size was calculated using G*Power software
(Heinrich-Heine-University Düsseldorf, version 3.1.9.2,
Düsseldorf, Germany), assuming an effect of exercising
with reduced muscle glycogen content on PGC-1α mRNA
expression of 1.34,17 an alpha of 0.05, and a desired power
of at least 0.80. We used PGC-1α mRNA expression as the
main primary outcome as this gene has been considered a
key regulator of mitochondrial biogenesis.33 The effective
sample size necessary to achieve statistical significance was
six participants; however, sample size was increased to eight
participants to account for potential dropouts or insufficient
muscle sample size due to technical problems.

2.2

|

Study overview

Each participant completed three experimental trials in
a crossover, randomized, and incomplete balanced Latin
Square counterbalanced measure design. The randomization
was performed using software available at http://www.rando
mized.org and controlled by an investigator of our laboratory
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who was not conscious of the aim of the study. All tests
were performed at Vitória Santo Antão Campus of Federal
University of Pernambuco from March to November 2015.
An overview of the experimental design is shown
in Figure 1. Briefly, in the once-daily approach participants performed the muscle glycogen-depleting exercise
in the evening (20:00-22:00 h) followed by an overnight
fast. The next morning (08:00 h), participants ate a lowcarbohydrate breakfast (carbohydrate: 42.7 ± 5.0 kcal, 7%;
fat: 365.9 ± 43.1 kcal, 60%; protein: 201.3 ± 23.7 kcal, 33%)
and then performed the high-intensity interval exercise session in the afternoon (13:00 h). In the twice-a-day approach,
participants ate a low-carbohydrate breakfast on the morning of the experimental day (08:00 h), and then performed
a muscle glycogen-depleting exercise (09:00-11:00 h), followed by a 2-hour rest period and the high-intensity interval
exercise (13:00 h). In the control condition, participants consumed the same low-carbohydrate breakfast as the two other
experimental trials (08:00 h), and then performed the same
high-intensity interval exercise session in the afternoon (ie,
13:00 h). Skeletal muscle biopsies from the vastus lateralis
and venous blood samples were taken before, immediately
after, and 3 hours after completion of the high-intensity interval exercise sessions. Participants were not allowed to eat
any food between the breakfast and the last muscle biopsy
in all experimental trials. Water was provided ad libitum
throughout each trial. Each experimental trial was separated
by approximately 2 weeks to washout any residual effect of
fatigue or damage caused by exercise and the multiple muscle
biopsies. The main primary outcome measure was PGC-1α
mRNA, while the second outcome measures were nuclear/
cytosolic proteins and other genes associated with mitochondrial biogenesis.

F I G U R E 1 Experimental design. D, dinner; B, breakfast; L, lunch; MG-DE, muscle glycogen-depleting exercise; HIIE, high-intensity
interval exercise. Open-dashed circles indicate that participants replicated their usual diet, while closed circles indicate that participants ate a
low-carbohydrate (CHO) breakfast (CHO: 42.7 ± 5.0 kcal [~7%], fat: 365.9 ± 43.1 kcal [~60%], protein: 201.3 ± 23.7 kcal [~33%]). Black arrows
indicate time point when muscle biopsies and blood samples were taken
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2.3
2.3.1

|

Exercise protocols

|

Preliminary test

One week prior to the commencement of this study, participants performed a graded exercise test to volitional fatigue
on a cycloergometer (Ergo-Fit 167, Pirmasens, Germany).
The test commenced at 50 W, and thereafter intensity was
increased by 25 W every 4 minutes, with a 1-minute break
between stages, until volitional exhaustion.35 The test was
interrupted when the participant could no longer maintain
the required cadence (70 rpm). Strong verbal encouragement
was provided to each participant.
̇ 2 was measured breath-by-breath throughout the test
VO
using an automatic analyzer (Cortex, Metalyzer 3B, Saxony,
Germany). Before each test, the gas analyzer was calibrated
using ambient air and a cylinder of known gas concentration
(12% O2 and 5% CO2). The volume was calibrated using a 3-L
syringe (Quinton Instruments, Washington, US). Capillary
ear lobe blood samples were taken at rest and immediately
after each 4-minute stage of the test for determination of
plasma lactate concentration. The first lactate threshold was
visually identified by two experienced investigators as the
first increase in plasma lactate concentration above resting
level. The second lactate threshold was calculated by the
modified Dmax method.36 This was determined by the point
on the polynomial regression curve that yields the maximal
perpendicular distance to the straight line connecting the first
̇ 2peak was
lactate threshold and the final stage of the test. VO
̇
defined as the highest 30-second average VO2 during the
test and peak power was determined as the highest workload
reached. If a participant did not complete the final 4-minute
stage, then the peak power was determined using the following equation:

Peak power = Plast + (t∕240 ⋅ 25)

(1)

where Plast is the power in Watts of the last completed stage
performed by the participant, t is the time (in seconds) sustained during the last incomplete stage, and 25 corresponds to
the increments in power (Watts) at each stage.

2.3.2

|

|

2.3.3

Muscle glycogen-depleting exercise

To reduce muscle glycogen stores, participants cycled for
100 minutes at a power corresponding to 50% of the difference between their first and second lactate thresholds
(124 ± 27 W, 54 ± 5% of peak power). Then, after an
8-minute rest, participants performed six 1-minute exercise
bouts at 125% of their peak power (287 ± 46 W) interspersed
with 1-minutes rest periods.37 This protocol has been shown
to be effective to reduce muscle glycogen content.38,39

|
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High-intensity interval exercise

The high-intensity interval exercise sessions were preceded
by a 5-minute warm-up at 90% of the first lactate threshold.
Participants completed ten 2-minute intervals at an intensity
of 20% of the difference between the second lactate threshold
and their peak power (182 ± 38 W, 79 ± 5% of peak power).
Each 2-minute bout was interspersed with a 1-minute passive
recovery period.35 Participants were required to maintain a
pedal frequency of 70-80 rpm during each 2-minute bout. The
̇
̇ 2, VCO
̇
VO
2, RER, and VE were measured breath-by-breath
throughout each high-intensity interval exercise session using
the same gas analyzer described for the graded exercise test.
Data were then converted to 30-second intervals and the last
30 seconds of each 2-minute bout were used for further analysis.

2.4 | Diet and exercise control before
starting experimental manipulation
Participants were asked to register all foods and beverages consumed during the 48-hour preceding the start of the preliminary
test. The usual macronutrient consumption was measured from
this diet recall using a computer program designed to perform
nutritional calculations (Nutwin, Nutrition Support Program,
version 1.5, Department of Health Informatics, Federal
University of São Paulo, Brazil). The daily energy and macronutrient intakes during the 48-hour preceding the first preliminary test were 3330 ± 475 kcal (43.2 ± 10.0 kcal·kg−1), 49% ±
6% carbohydrates (409.3 ± 79.4 g, 5.3 ± 1.4 g·kg−1), 27% ± 5%
lipids (101.5 ± 28.2 g, 1.3 ± 0.5 g·kg−1), and 24% ± 7% protein
(195.0 ± 43.8 g, 2.5 ± 0.5 g·kg−1). Participants were asked to
replicate the dinner of two days before (day 1), and breakfast,
lunch and dinner of one day before the experimental trial (day 2)
(Figure 1). Participants were given verbal and written instructions describing how to repeat this before each subsequent
experimental trial. Checklists were used to check any deviations from the menu, and analysis of checklists showed no differences for energy or macronutrient intake between conditions
during these meals (Table 1). Participants were also instructed
to avoid any strenuous exercise as well as alcohol and caffeine
consumption for the 24 hours prior to each experimental trial.

2.5

|

Blood collection and analysis

Blood samples were collected from an antecubital vein and
separated into three different tubes. Two milliliters of blood
were collected in tubes containing sodium fluoride and EDTA
(Hemogard Fluoride/EDTA, BD Vacutainer, USA). Blood was
centrifuged at 4000 rev·min−1 for 10 minutes at 4°C with the
resulting plasma transferred to 2-mL tubes and immediately
analyzed for plasma glucose and lactate concentrations. Plasma

1606
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TABLE 1

Analysis of checklists for energy or macronutrient intake between conditions for the dinner eaten 2 days before, and breakfast,
lunch, and dinner eaten 1 day before the experimental trial
Dinner 2 days before the
experimental trial

Breakfast 1 day before
the experimental trial

Lunch 1 day before the
experimental trial

Dinner 1 day before the
experimental trial

Control

911 ± 348

613 ± 358

955 ± 233

852 ± 215

Twice-a-day

918 ± 354

602 ± 366

925 ± 236

886 ± 237

Once-daily

887 ± 334

602 ± 366

948 ± 236

884 ± 236

Energy intake (Kcal)

Carbohydrate (%)
Control

45 ± 19

52 ± 12

44 ± 5

50 ± 9

Twice-a-day

45 ± 19

53 ± 12

46 ± 6

49 ± 9

Once-daily

43 ± 18

53 ± 12

44 ± 5

49 ± 9

Control

28 ± 17

17 ± 8

32 ± 5

21 ± 12

Twice-a-day

28 ± 17

17 ± 8

33 ± 6

21 ± 12

Once-daily

28 ± 17

17 ± 8

34 ± 7

21 ± 12

Control

27 ± 10

31 ± 7

23 ± 10

29 ± 8

Twice-a-day

27 ± 10

30 ± 8

21 ± 11

30 ± 9

Once-daily

30 ± 10

30 ± 8

21 ± 11

30 ± 9

Protein (%)

Lipids (%)

Note: Data are presented as mean ± standard deviation. n = 8 for all variables.

glucose and lactate concentrations were analyzed with a commercially available enzymatic kit (Glucose Liquiform and
Enzymatic Lactate, respectively, Labtest, Lagoa Santa, Minas
Gerais, Brazil). A further 8 mL of blood was collected in tubes
containing Clot activator and gel for serum separation (SST II
Plus, BD Vacutainer, USA), and another 3 mL of blood was
collected in tubes containing sodium heparin (Sodium HeparinN
Plus, BD Vacutainer, USA). Both were then centrifuged at
4000 rev·min−1 for 10 minutes at 4°C, and the resulting serum/
plasma frozen and stored in liquid nitrogen for the later analysis
of free fatty acid, glycerol, and catecholamine concentrations in
the serum/plasma. Serum free fatty acid and glycerol concentrations were determined by an enzymatic colorimetric method
(EFFA-100 and EGLY-200, BioAssay, Hayward, California,
USA). Plasma catecholamine concentrations were determined
using ion-pairing reverse phase liquid chromatography coupled
with electrochemical detection.37

2.6

|

Muscle tissue samples and analysis

Nine separate incisions (three per trial) were made into the
vastus lateralis under local anaesthesia (2% Xylestesin), and
a muscle sample taken using a Bergström needle40 adapted
for manual suction.41 Samples were taken approximately
1 cm apart from a previous biopsy site. Samples (mean:
118 ± 48 mg; range: 49-248 mg) were immediately snapfrozen in liquid nitrogen, and then stored at −80ºC until

subsequent analyses. Muscle samples were taken at rest (pre),
immediately after (post) and 3 hours after the high-intensity
interval exercise (3 h post). Biopsies were subsequently analysed for muscle glycogen content, as well as gene and protein expression (described subsequently).

2.7

|

Muscle glycogen concentration

Approximately 2-3 mg of freeze-dried muscle tissue was
powdered and dissected free of all visible nonmuscle tissue.
Powdered muscle tissue was then extracted with 250 µL of
2 M HCl, incubated at 95°C for 2 hours (agitated gently every
20 min), and then neutralized with 750 µL of 0.66 M NaOH.
Glycogen concentration was subsequently assayed in triplicate
via enzymatic analysis with fluorometric detection42 and the
mean value reported as millimoles per kilogram dry weight.

2.8

|

Western blotting

2.8.1 | Muscle homogenate preparations and
protein assays
Approximately 20 mg of frozen muscle tissue was homogenized using a TissueLyser II (Qiagen, Valencia, CA) in a 1:20
dilution of ice-cold RIPA buffer (pH 7.4) containing: 0.15 M
NaCl, 1% Triton-X100, 0.5% sodium deoxycholate, 0.05 M

   

ANDRADE-SOUZA et al.

Tris, 0.1% SDS, 0.1 M EDTA, with the addition of protease/
phosphatase inhibitor cocktail (Cell Signaling Technology
[CST], #5872, St. Louis, MI). Homogenates were rotated endover-end for 60 minutes at 4°C. Protein content of muscle homogenate was measured in triplicate using a Bradford assay
(Bio-Rad protein assay dye reagent concentrate, Bio-Rad
Laboratories, Hercules, CA) against bovine serum albumin
standards (BSA, A9647, Sigma-Aldrich). Nuclear and crude
cytosolic fractions were prepared from 40 to 60 mg of wet
muscle using a commercially available nuclear extraction kit
(NE-PER, Pierce, USA). Muscle samples were homogenized
in cytoplasmic extraction reagent I buffer containing a protease/phosphatase inhibitor cocktail (CST, 5872). Following
centrifugation (16 000 g for 5 min at 4°C), the supernatant was
taken and pellets containing nuclei were washed 5 times in
PBS to remove cytosolic contamination, before nuclear proteins were extracted by centrifugation (16 000 g for 10 min
at 4°C) in high-salt nuclear extraction reagent buffer supplemented with the same inhibitors cocktail following manufacturer's instruction. Verification of subcellular enrichment is
presented in Figures 3B and 4B. Sufficient muscle was available to prepare subcellular fractions from all eight participants.

2.8.2

|

Immunoblotting

RIPA-buffered homogenate was diluted in 4X Laemmli buffer
(0. 25 M Tris, 8% SDS, 40% glycerol, 0.04% bromophenol
blue, 20% 2-mercaptoethanol) and equal amounts of total
protein (10-20 µg) were loaded on Criterion 4%-20% TGX
Stain-Free Precast Gels (Bio-Rad). All samples for a participant were loaded in adjacent lanes on the same gel. Four to six
different dilutions of a mixed-homogenate internal standard
were also loaded on each gel and a calibration curve plotted
of density against protein content. From the subsequent linear
regression equation protein abundance was calculated from
the measured band intensity for each sample on the gel.43 Gel
electrophoresis ran for 90 minutes at 80-150 V. Proteins were
turbo-transferred to a 0.2-µm PVDF membrane at 25 V for
10 minutes. Membranes were blocked for 60 minutes at room
temperature in 5% nonfat dry milk diluted in Tris-buffered
saline with 0.1% Tween-20 (TBST). Membranes were then
washed in TBST and incubated overnight at 4°C—with the
appropriate primary antibody: Histone H3 (CST, 44 995),
LDHA (CST, 2012), PGC-1α (CST, 2178), p-ACCSer79 (CST,
3361), 5′ adenosine monophosphate-activated protein kinase
(AMPK) (CST, 2532), p-AMPKThr172 (CST, 2531), p38
MAPK (CST, 9212), p-p38 MAPKThr180/Tyr182 (CST, 9211),
PHF20 (CST, 3934), p53 (CST, 2527), TFEB (CST, 9601),
and NFAT2 (CST, 8032) diluted (1:1000) in 5% BSA and
0.02% sodium azide in TBST. Following TBST washes the
membranes were incubated in the relevant secondary antibody: Goat anti-rabbit IgG (Perkin Elmer/NEF812001EA),

|
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diluted (1:10 000) in 5% nonfat dry milk in TBST, for 60 minutes at room temperature. After further washes, membranes
were developed using Clarity ECL (Bio-Rad) and images
were taken with a ChemiDoc Imaging System fitted (BioRad). Densitometry was performed with Image Lab 5.0 software (Bio-Rad). Images are typically displayed with at least
five bandwidths above and below the band of interest.

2.9
2.9.1

|

Real-Time quantitative PCR

|

RNA extraction

Total RNA from approximately 10-15 mg of frozen muscle was homogenized in 800 µL of TRIzol reagent (Thermo
Fisher Scientific, Waltham, USA) using a TissueLyser II
(Qiagen).44 The concentration and purity of each sample
was assessed using a NanoDrop One/Onec (Thermo Fisher
Scientific). RNA integrity of a subset of samples was measured using a Bio-Rad Experion microfluidic gel electrophoresis system with Experion RNA StdSens Analysis kit
(Bio-Rad, 7 007 104). All tested samples showed good quality (RNA quality indicator >7). RNA was stored at −80°C
until reverse transcription was performed.

2.9.2

|

Reverse transcription

1 µg RNA, in a total reaction volume of 20 µL, was reverse transcribed to cDNA using a Thermocycler (Bio-Rad) and iScript
RT Supermix (Bio-Rad, 170-8840) per the manufacturer's
instructions. Priming was performed at 25°C for 5 minutes
and reverse transcription for 30 minutes at 42°C. All samples,
including RT-negative controls, were performed during the
same run. cDNA was stored at −20°C until subsequent analysis.

2.9.3

|

qPCR

Relative mRNA expression was measured by qPCR
(QuantStudio 7 Flex, Applied Biosystems, Foster City, CA)
using SsoAdvanced Universal SYBR Green Supermix (BioRad). Primers were designed using Primer-BLAST45 to
include all splice variants, and were purchased from SigmaAldrich (see Table S1 for primer details). All reactions were
performed in duplicate on 384-well MicroAmp optical plates
(4 309 849, Applied Biosystems) using an epMotion M5073
automated pipetting system (Eppendorf AG). Total reaction
volume of 5 µL contained 2 µL of diluted cDNA template,
2.5 µL of mastermix, and 0.3 µM or 0.9 µM primers. All assays
ran for 10 minutes at 95°C, followed by 40 cycles of 15 seconds
at 95°C and 60 seconds at 60°C. The stability of six potential reference genes were determined by BestKeeper46 and

|   
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NormFinder47 software, and the three most stably expressed
genes were TATA box-binding protein (TBP), 18S ribosomal
RNA (18S), and actin beta (ACTB) (Table S1). There were no
main effects of training approach, time, nor interaction effects,
for the quantification cycle (Ct) values of the three most stable
housekeeping genes (P > .05). Expression of each target gene
was normalized to the geometric mean of expression of the
three reference genes,48 and using the 2−ΔΔCt method.49

|

2.10

Statistical analysis

Statistical analysis was performed using the GraphPad Prism
software version 6.01. All data were checked for normality with the Kolomogorov-Smirnov test. To compare the
responses before, immediately after, and 3 hours after each
high-intensity interval exercise session, data were analyzed
with two-way repeated measures ANOVA (trial vs. time). A
Bonferroni post hoc test was used to locate the differences.
All values are expressed as means ± SD. Significance was
accepted when P < .05.

3
3.1

|

R ES U LTS

|

Muscle glycogen concentration

Prior to the high-intensity interval exercise, muscle glycogen
concentration was similarly lower in both the twice-a-day
and once-daily conditions, compared to the control condition (~45% and 42%, respectively; Figure 2). Compared to
their respective rest values, muscle glycogen concentration

decreased similarly after the high-intensity interval exercise
in all three conditions (from 245.0 to 135.7 mmol·kg−1 dry
mass in the twice-a-day, from 262.2 to 163.7 mmol·kg−1 dry
mass in the once-daily, and from 449.2 to 312.2 mmol·kg−1
dry mass in the control; ~45%, 38%, and 30% of reduction for
twice-a-day, once-daily and control, respectively; P < .05;
Figure 2), and remained lower 3 hours postexercise in both
the twice-a-day and once-daily conditions, compared to the
control condition (~46% and 43%, respectively; Figure 2).

3.2

Cytosolic proteins relative abundance

Representative blots are presented in Figure 3A,B. Cytosolic p53
protein relative abundance increased immediately post the highintensity interval exercise in all three conditions (Figure 3D),
with no differences between conditions. Cytosolic PGC-1α,
phosphorylated p53 (p-p53Ser15), PHF20 protein (PHF20),
TFEB, p38 mitogen-activated protein kinase (p38 MAPK),
phosphorylated 5′ adenosine monophosphate-activated protein
kinase (p-AMPKThr172), and NFAT relative abundance were unaffected by the exercise approach or time (Figure 3C,E-J).

3.3

|

Nuclear protein relative abundance

Representative blots are presented in Figure 4A,B. Nuclear
PGC-1α, p53, and p-p53Ser15 relative abundance increased
post the high-intensity interval exercise (Figure 4C-E), with
no clear differences between the three conditions. The relative
abundance of nuclear PHF20, p38MAPK, and p-AMPKThr172
was unaffected by either “train-low” approach or time
(Figure 4F-H). However, nuclear TFEB relative abundance
was greater in the twice-a-day compared to the once-daily
condition both pre and post the high-intensity interval
exercise (Figure 4I). Moreover, nuclear NFAT relative abundance was also greater in the twice-a-day compared to both
the once-daily and control condition post the high-intensity
interval exercise (Figure 4J).

3.4

F I G U R E 2 Muscle glycogen concentration pre-, post-, and
3 h post the high-intensity interval exercise. Data are presented as
mean ± standard deviation. n = 8. *Significantly lower than control at
the same time point (P < .05). #Significantly lower than pre the highintensity interval exercise for the same condition (P < .05). Two-way
analysis of variance (ANOVA) with Bonferroni post hoc test

|

|

Mitochondrial-related gene expression

Pre the high-intensity interval exercise, total PGC-1α mRNA
content was ~9-fold higher in the twice-a-day compared
to both the once-daily and control conditions (Figure 5A).
Three hours post the high-intensity interval exercise, total
PGC-1α mRNA content increased in all three conditions
compared with their respective pre values; however, total
PGC-1α mRNA content remained ~10-fold higher in the
twice-a-day compared to both control and once-daily conditions. Similarly, PGC-1α isoform 4 mRNA content was
~24-fold higher at pre the high-intensity interval exercise in

ANDRADE-SOUZA et al.

   

|

1609

F I G U R E 3 Cytosolic protein relative abundance pre and post the high-intensity interval exercise. A, Representative immunoblots
corresponding to total and phosphorylated protein relative abundance measured in the cytosolic fraction, pre and post the high-intensity interval
exercise in the control, twice-a-day, and once-daily approaches. B, LDHA was used as an indicator of cytosolic enrichment. N: nuclear fractions;
C: cytosolic fractions; C, cytosolic peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1α); D, cytosolic p53 (p53); E, cytosolic
phosphorylated p53 (p-p53Ser15); F, cytosolic PHF20 (PHF20); G, cytosolic phosphorylated 5′ adenosine monophosphate-activated protein kinase
(p-AMPKThr172); H, cytosolic phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK); I, cytosolic transcription elongation factor
EB (TFEB); J, cytosolic nuclear factor of activated T cells (NFAT). n = 8 for all proteins. Data are presented as fold changes from control pre
(mean ± standard deviation). #Significantly higher than pre the high-intensity interval exercise for the same condition (P < .05). Two-way analysis
of variance (ANOVA) with Bonferroni post hoc test

the twice-a-day compared to both the once-daily and control
conditions (Figure 5C). At 3 hours posthigh-intensity interval
exercise, the PGC-1α isoform 4 mRNA content increased in
all three conditions compared with their respective prevalues;
however, the PGC-1α isoform 4 mRNA content remained
~10-fold higher in the twice-a-day compared to the control
and once-daily conditions. Additionally, PGC-1α isoform 1

mRNA content was higher in the twice-a-day compared to the
once-daily when all time points where considered (Figure 5B).
There was no effect of condition for p53, TFEB, chromodomain-helicase-DNA-binding protein 4 (CHCHD4), p21,
mitochondrial transcription factor A (Tfam), NADH dehydrogenase subunit β (NDUFβ; mitochondrial complex I),
succinate dehydrogenase subunit β (SDHβ; mitochondrial
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F I G U R E 4 Nuclear protein relative abundance pre and post the high-intensity interval exercise. A, Representative immunoblots
corresponding to total and phosphorylated protein relative abundance measured in the nuclear fraction, pre and post the high-intensity interval
exercise in the control, twice-a-day, and once-daily approaches. B, H3 was used as an indicator of nuclear enrichment. N: nuclear fractions;
C: cytosolic fractions; C, nuclear peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1α); D, nuclear p53 (p53); E, nuclear
phosphorylated p53 (p-p53Ser15); F, nuclear PHF20 (PHF20); G, nuclear phosphorylated AMPKThr172 (p-AMPKThr172); H, nuclear phosphorylated
p38MAPK (p-p38MAPK); I, nuclear transcription elongation factor EB (TFEB); J, nuclear factor of activated T cells (NFAT). n = 8 for all
proteins. Data are presented as fold changes from control pre (mean ± standard deviation). *Significantly higher than the once-daily and control
condition at the same time point (P < .05). †Significantly higher than the once-daily condition at the same time point (P < .05). #Significantly
higher than pre high-intensity interval exercise for the same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc
test

complex II), cytochrome c (mitochondrial complex III), and
cytochrome c oxidase subunit IV (COX IV; mitochondrial
complex IV) mRNA content post the high-intensity interval exercise (Figure 5D-L). However, the mRNA content of
representative subunits of mitochondrial complexes II, III,
and IV increased 3 hours post the high-intensity interval
exercise to a similar extent for all three conditions.

3.5 | Fat transport and lipolysisrelated genes
The content of carnitine palmitoyltransferase I subunit A
(CPT1A) mRNA was higher in both the twice-a-day and
once-daily conditions compared with the control condition
at 3 hours post the high-intensity interval exercise; however,

ANDRADE-SOUZA et al.
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F I G U R E 5 Mitochondrial-related gene expression pre-, post-, and 3 h post the high-intensity interval exercise. A, peroxisome proliferatoractivated receptor-γ coactivator-1 (PGC-1α) total gene expression; B, PGC-1α isoform 1 gene expression; C, PGC-1α isoform 4 gene expression;
D, p53 (p53) gene expression; E, transcription elongation factor EB (TFEB) gene expression; F, Chromodomain-helicase-DNA-binding protein
4 (CHCHD4) gene expression; G, p21 protein (p21) gene expression; H, mitochondrial transcription factor A (Tfam) gene expression; I, NADH
dehydrogenase (NDUFβ) (mitochondrial complex I) gene expression; J, succinate dehydrogenase subunit β (SDHβ) (mitochondrial complex II)
gene expression; K, cytochrome c (mitochondrial complex III) gene expression; L, cytochrome c oxidase subunit IV (COXIV) (mitochondrial
complex III) gene expression. n = 8 for all genes (except Tfam, n = 7). Data are presented as fold changes from control pre (mean ± standard
deviation). *Significantly higher than the once-daily and control condition at the same time point (P < .05). #Significantly higher than prehighintensity interval exercise for the same condition (P < .05). ɸSignificantly higher than posthigh-intensity interval exercise for the same condition
(P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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there was no difference between the two “train-low” approaches (Figure 6A). There was an increase in mitochondrial uncoupling protein 3 (UCP3) mRNA content 3 hours
post exercise in all three conditions. The UCP3 mRNA content was, however, significantly higher only in the twice-a-day
compared to the control condition at 3 hours post the highintensity interval exercise (Figure 6B). Pre the high-intensity
interval exercise, the PPARα mRNA content was ~11-fold
higher in the twice-a-day compared to both the once-daily
and control conditions (Figure 6C). Three hours post the
high-intensity interval exercise, the PPARα mRNA content
increased ~7- and 9-folds in the once-daily and control conditions, respectively, compared with their respective pre-values;
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however, the PPARα mRNA content remained ~16-fold
higher in the twice-a-day compared to the once-daily and
control conditions. The PPARβ/δ mRNA content was higher
in the twice-a-day than in the control condition post the highintensity interval exercise, and higher than both the oncedaily and control conditions at 3 hours post the high-intensity
interval exercise (Figure 6D). The PPARβ/δ mRNA content
was higher at 3 hours post the high-intensity interval exercise
compared to pre and post only for the twice-a-day approach.
The citrate synthase (CS) mRNA content was higher 3 hours
post the high-intensity interval exercise compared to post for
all three conditions. However, the peroxisome proliferatoractivated receptor gamma (PPARγ), β-hydroxyacyl-CoA

F I G U R E 6 Genes-related to fat transport and lipolysis pre-, post-, and 3 h post the high-intensity interval exercise. A, carnitine
palmitoyltransferase I (CPT1) gene expression; B, mitochondrial uncoupling protein 3 (UCP3) gene expression; C, peroxisome proliferatoractivated receptor α (PPARα) gene expression; D, peroxisome proliferator-activated receptor β/δ (PPARβ/δ) gene expression; E, peroxisome
proliferator-activated receptor γ (PPARγ) gene expression; F, citrate synthase (CS) gene expression; G, β-hydroxyacyl-CoA dehydrogenase
(β-HAD) gene expression; H, fatty acid translocase cluster of differentiation 36 (CD-36) gene expression. n = 8 for all genes (except CS and UCP3,
where n = 7). Data are presented as fold changes from control pre (mean ± standard deviation). *Significantly higher than the once-daily condition
at the same time point (P < .05). †Significantly higher than the control condition at the same time point (P < .05). #Significantly higher than
pre the high-intensity interval exercise for the same condition (P < .05). ɸSignificantly higher than post the high-intensity interval exercise for the
same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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dehydrogenase (β-HAD), and fatty acid translocase cluster of
differentiation 36 (CD-36) mRNA content were unaffected by
the “train-low” approach or time (Figure 6E-H).

3.6

|

Glycolysis-related genes

The mRNA content of phosphofructokinase (PFK) and glucose transporter 4 (GLUT4) was unaffected by the exercise
approach or time. While pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) mRNA content increased 3 hours post the

|
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high-intensity interval exercise, there was no difference for
the three different exercise approaches (Figure 7A-C).

3.7

|

Physiological responses

The twice-a-day approach was associated with a higher
heart rate, ventilation, and oxygen uptake, and a lower
plasma glucose concentration, during high-intensity interval exercise than both the once-daily and the control
condition (Figure 8A-C and Table 2). Plasma glucose was

F I G U R E 7 Genes related to carbohydrate metabolism pre-, post-, and 3 h post the high-intensity interval exercise. A, phosphofructokinase
(PFK) gene expression; B, glucose transporter 4 (GLUT4) gene expression; C, pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) gene
expression. n = 8 for all genes. Data presented as fold changes from control pre (mean ± standard deviation). #Significantly higher than prehighintensity interval exercise for the same condition (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test

FIGURE 8

̇ ); C,
Physiological and systemic responses during the high-intensity interval exercise. A, Heart rate (HR); B, Ventilation (VE
̇ 2); D, Respiratory exchange ratio (RER). n = 8 for all variables. Data are presented as mean ± standard deviation. Time effect
Oxygen uptake (VO
has been omitted for clarity. INT: Interval. Two-way analysis of variance (ANOVA) with Bonferroni post hoc test
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TABLE 2

Plasma lactate, glucose, epinephrine and norepinephrine concentrations, and serum-free fatty acid and glycerol concentrations pre-,
post- and 3 h post the high-intensity interval exercise
Pre

Post

3 h post

Plasma
Lactate (mmol·L−1)
Control

6.2 ± 2.0d

1.2 ± 0.7

1.3 ± 0.4

b,d

1.2 ± 0.4

Once-daily

0.9 ± 0.3

3.9 ± 1.0

Twice-a-day

1.4 ± 0.5

4.0 ± 1.6b,d

2.0 ± 0.7

5.2 ± 0.8

5.5 ± 0.9

5.3 ± 0.8

−1

Glucose (mmol·L )
Control
Once-daily
Twice-a-day

b

5.2 ± 0.5

5.0 ± 0.8

4.4 ± 0.7a,b

4.8 ± 1.1b,d

4.8 ± 0.7b,c
4.3 ± 1.0a,b

−1

Epinephrine (pg·mL )
Control

32.2 ± 18.4

39.3 ± 22.7

36.7 ± 17.8

Once-daily

56.7 ± 25.4

54.2 ± 25.7

35.8 ± 34.8

Twice-a-day

43.1 ± 13.6

43.7 ± 19.0

36.7 ± 10.4

68.0 ± 34.6

231.1 ± 141.8d

120.4 ± 90.3

Once-daily

70.7 ± 33.8

350.6 ± 139.8

d

105.5 ± 77.5

Twice-a-day

76.7 ± 49.1

287.5 ± 147.6d

113.8 ± 44.6

Norepinephrine (pg·mL−1)
Control

Serum
Free Fatty Acid (µM)
Control

194.9 ± 118.2

118.6 ± 72.6

130.3 ± 72.1

Once-daily

155.5 ± 79.9

236.5 ± 151.4

158.0 ± 62.8

Twice-a-day

209.9 ± 125.5b

260.6 ± 151.3b

230.4 ± 98.2b

0.105 ± 0.021

0.098 ± 0.025

0.098 ± 0.037

Glycerol (mmol·L−1)
Control
Once-daily
Twice-a-day

0.090 ± 0.037

b

0.100 ± 0.039

b

0.102 ± 0.023

0.141 ± 0.022

0.106 ± 0.031

0.169 ± 0.046

Note: Data are presented as mean ± standard deviation. n = 8 for all variables.
a

Significantly different from the once-daily at the same time point (P < .05).

b

Significantly different from the control condition at the same time point (P < .05).

c

Significantly different from pre the high-intensity interval exercise for the same condition (P < .05).

d

Significantly different from pre- and post the high-intensity interval exercise for the same condition, except for glucose that was significantly different only from
post the high-intensity interval exercise (P < .05). Two-way analysis of variance (ANOVA) with Bonferroni post hoc test.

also lower during the high-intensity interval exercise in the
once-daily compared to the control condition (Table 2). In
addition, the respiratory exchange ratio was lower and the
serum-free fatty acid concentration higher than the control
only for the twice-a-day approach (Figure 8D and Table 2).
Serum glycerol was higher and plasma lactate lower post
the high-intensity interval exercise in both the twice-a-day
and once-daily conditions compared with the control condition (Table 2). Plasma epinephrine and norepinephrine
concentrations were not influenced by the exercise approach undertaken.

4
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DISCUSSION

There is continued debate about whether beginning exercise
with low muscle glycogen stores potentiates the exerciseinduced increase in genes associated with mitochondrial biogenesis and metabolism.11,12,50-54 Some of this controversy
may relate to the observation that some of the evidence supporting the “train-low” approach is based on performing the
experimental exercise session a few hours after a glycogenlowering exercise session.21-24,26-28 Thus, it is difficult to
determine if any observed effects are due to performing the
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second exercise session with low muscle glycogen stores
and/or performing the second exercise session close to
the first. We investigated this question by performing the
same exercise session with similar starting muscle glycogen stores, but either 2 or 15 hours following the previous
glycogen-lowering exercise session. Our results indicate
that the greater exercise-induced nuclear protein abundance
(TFEB and NFAT) and transcription of genes involved in
mitochondrial biogenesis (PGC-1α, PPARα, PPARβ/δ)
with the so-called “train-low” approach might be attributed
to performing two exercise sessions in close proximity.
Despite the different recovery periods between exercise
sessions for the two “train-low” approaches, muscle glycogen
prior to the high-intensity interval exercise was reduced to a
similar extent in both the twice-a-day and once-daily condition compared with the control condition (Figure 2). This
level of muscle glycogen concentration is consistent with
previous studies that have utilized either the twice-a-day22,23
or once-daily20 approach. In addition, muscle glycogen concentration before commencing the high-intensity exercise
was below 300 mmol·kg−1·dry mass for both the twice-aday and once-daily conditions. Post the high-intensity interval exercise muscle glycogen concentration remained above
100 mmol·kg−1·dry mass. These values have been suggested
as an “upper” and “lower” limit threshold, respectively, for
which muscle glycogen levels may modulate genes related
to mitochondrial biogenesis.54 Thus, the similar low muscle
glycogen levels when commencing the high-intensity interval
exercise in both “train-low” conditions allowed us to determine whether any differences for exercise-induced gene or
protein expression could be attributed to performing highintensity interval exercise with reduced muscle glycogen
stores or to performing high-intensity interval exercise close
to a previous exercise session.
In the present study, both p-AMPK- and p-p38 MAPKrelative protein abundance in both the cytosolic and nucleus
fractions was not altered with exercise or influenced by either
“train-low” approach (Figure 4G,H). It has been suggested that
the greater exercise-induced upregulation of cell-signaling
pathways with reduced muscle glycogen content may be associated with enhanced nuclear and cytosolic abundance
and greater activation of p-AMPK and p-p38 MAPK,15,16,55
but contradictory results have been reported.20,22,26,56 For
example, Cochran et al26 observed larger increases in cytosolic p-p38 MAPK but not p-AMPK with the twice-a-day
approach, while Yeo et al22 reported larger increases in
cytosolic p-AMPK but without alterations in p-p38 MAPK
with the twice-a-day compared to the once-daily approach.
On the other hand, Gejl et al56 and Psilander et al20 found no
effect of either the twice-a-day or once-daily approach on both
p-AMPK and p-p38 MAPK protein content in cytosolic fractions. In addition, Chan et al15 and Steinberg et al16 reported
an increase in nuclear abundance of p-p38 MAPK and AMPK,
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respectively, with the once-daily approach. The explanation
for these contradictory results is unclear, but it is worth noting both the glycogen-depleting exercise and the “depletedexercise” varied considerably in these studies; either high-26,56
or low-intensity15,16,20,22 exercise was used to reduce muscle
glycogen, and high-22,26 or low-intensity15,16,20,56 exercise was
implemented during the second exercise session (depletedexercise). However, activation of AMPK and p38 MAPK does
not seem to be associated with muscle glycogen levels or a
particular train-low regime.57 Thus, it remains to be solved
which protocol or strategy might induce augmented activation
of p-AMPK and p-p38 MAPK.
Although p-AMPK and p-p38 MAPK relative protein
abundance in the cytosolic and nucleus were not altered
with exercise or “train-low” approaches, there was greater
PGC-1α, p-p53, and p53 relative protein abundance in the
nucleus immediately post the high-intensity interval exercise (Figure 4C-E). There was also a higher p53 cytosolic
protein abundance post the high-intensity interval exercise
(Figure 3D). The increased nuclear and cytosolic p53 abundance are consistent with the well-accepted notion that cellular stress is associated with accumulation of p53 protein—a
process that has been partly attributed to increased p53 protein stability.58,59 Nevertheless, we found no significant differences between either of the “train-low” approaches and
the control condition for p-p53 and p53 relative protein abundance in either subcellular fraction. The “train-low” approach
has been associated with a greater exercise-induced cytosolic
relative protein abundance of p-p53,17 which is suggested to
influence the gene expression of PGC-1α.60 As differences
in neither p-p53 nor p53 protein content in the nucleus could
explain the greater exercise-induced increases in PGC-1α
gene expression with the different train-low approaches
in the present study, we subsequently investigated the
nuclear abundance of other proteins that may contribute to the
exercise-induced regulation of this gene.
The nuclear abundance of NFAT increased significantly
after performing high-intensity interval exercise only in the
twice-a-day condition, and post-exercise values were higher
than both the control and once-daily conditions (Figure 4J).
In addition, in both the pre- and postexercise muscle samples the nuclear abundance of TFEB was significantly greater
with the twice-a-day compared to the once-daily approach
(Figure 4I). As activated calcineurin dephosphorylates both
NFAT61,62 and TFEB,63-65 leading to their translocation to the
nucleus,61-66 this suggests there might be greater calcineurin
activation when high-intensity interval exercise is performed
soon after a prior exercise session. Although we did not
have sufficient muscle sample to test this hypothesis, in the
twice-a-day condition we observed significantly greater exercise-induced increases of genes that have been reported to be
regulated by calcineurin (eg, PGC-1α, PPARα, and PPARβ/
δ66,67).
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In contrast to our findings, some studies have reported
greater exercise-induced increases in PGC-1α mRNA with
the once-daily approach (~6-fold from rest) when compared to a control condition (~3-fold from rest).17,19,20 This
previously reported ~6-fold increase in PGC-1α mRNA
with the once-daily approach is of similar magnitude to
the PGC-1α mRNA increase with the once-daily approach
in the present study (~6 fold from rest), although this was
not significantly different to the change we observed in
the control condition (~6-fold from rest). However, we did
observe a significantly greater exercise-induced increase
in PGC-1α (and PPARα, PPARβ/δ) mRNA content in the
twice-a-day condition, even though muscle glycogen content before commencing the high-intensity interval exercise was similar between the twice-a-day and once-daily
conditions, and both were lower than control. Our findings
therefore suggest that the greater exercise-induced increase
in these genes in our study can be attributed to performing the high-intensity interval exercise soon after the prior
exercise session, rather than beginning the high-intensity
interval exercise with lowered muscle glycogen levels. It
should be mentioned, however, that carbohydrate might
still play a role in myocellular signaling as ingesting exogenous carbohydrate between the two exercise sessions has
been reported to block the stimulus for inducing oxidative
enzyme adaptations in skeletal muscle.26,28
In the twice-a-day condition we also observed a greater
circulating free fatty acid concentration pre-, post-, and
3 hours post the high-intensity interval exercise (Table 2).
Although respiratory exchange ratio values were always
below 1.0 after the third interval, and systematically
lower in the twice-a-day compared to the control condition (Figure 8), which could be indicative of greater fat
oxidation, this conclusion is limited by the use of nonprotein respiratory quotient to calculate substrate oxidation
during nonsteady state exercise.68 The increase in circulating free fatty acids, however, might activate calcineurin69
and regulate skeletal muscle metabolism via coordinated
changes in gene expression.66 As previously mentioned,
activated calcineurin will lead to the translocation of both
NFAT and TFEB to the nucleus61-66 and the subsequent
upregulation of genes related to fat metabolism.66 These
exercise-induced changes are consistent with studies that
have reported greater increases in fat oxidation when training twice-a-day.21,23
Caution is required when extrapolating the acute
responses of exercising twice-a-day to the chronic effects
of training with this approach. We have recently conducted
a study comparing the magnitude of changes in molecular, functional, and morphological parameters linked to
mitochondrial biogenesis after 3 weeks of twice-a-day
or once-daily training.34 Despite similar improvements
in endurance performance with both train-low strategies,
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markers of mitochondrial biogenesis (citrate synthase activity and mitochondrial area) were not altered with either
train-low approach.34 These findings could be interpreted
to suggest that differences between twice-a-day and oncedaily approaches for the acute molecular responses associated with mitochondrial biogenesis might not be translated
to different adaptations in mitochondrial content after a
training period. However, 3 weeks of training might not
be long enough to induce a significant increase in mitochondrial content.7 Three weeks of twice-a-day but not
once-daily training did increase mitochondrial efficiency,
which is in accordance with the assumption that functional
alterations may precede morphological changes.70 Further
research is required to determine if longer training period
(ie, >3 weeks) using the twice-a-day approach results in
greater changes in mitochondrial content.
Our study has some limitations that should be mentioned. First, as we were constrained by the number of
muscle biopsies we could take, we elected to take our final
muscle biopsy 3 hours post exercise as most of the key genes
investigated in the present study have been reported to peak
~3 hours after exercise (eg, PGC-1α and PPARβ/δ).5,71
However, other genes might peak later (eg, CD-36)14 and
we may have underestimated the influence of the two
“train-low” approaches on some genes. Similarly, we did
not perform muscle biopsies immediately and 3 hours after
the muscle glycogen-depleting exercise; therefore, relevant
changes in molecular signaling following the first exercise
session in the once-daily condition may have been missed.
Second, consistent with most related research,17,19,24,26-28
we recruited participants who were active (~3.3 h of aerobic training per week) but who were not well-trained athletes. While this may limit the applicability of our findings
to elite athletes, it is difficult to perform similar experiments requiring multiple muscle biopsies in well-trained
athletes. Thus, further studies comparing different “trainlow” approached in well-trained athletes are required.
In summary, our findings indicate that the greater
exercise-induced signaling with the so-called “train-low”
approach in our study can partially be attributed to the performance of two exercise sessions in close succession rather
than exercising with a reduced muscle glycogen content. We
presented evidence that performing two exercise sessions
separated by a short recovery period increases the nuclear
abundance of TFEB and NFAT and potentiates the transcription of PGC-1α, PPARα, and PPARβ/δ.
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